Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 546 | 715 | 1,425 | 1,766 | 941 |
| Gross Profit | 546 | 715 | 1,425 | 1,766 | 941 |
| Operating Expenses | 12,390 | 12,972 | 19,366 | 13,888 | 8,705 |
| Operating Income | -11,844 | -12,257 | -17,941 | -12,122 | -7,764 |
| Other Income | 431 | 478 | 702 | 2,720 | 521 |
| Pre-tax Income | -11,413 | -11,779 | -17,239 | -9,402 | -7,243 |
| Net Income Continuous | -11,413 | -11,779 | -17,239 | -9,402 | -7,243 |
| Net Income | $-11,413 | $-11,779 | $-17,239 | $-9,402 | $-7,243 |
| EPS Basic Total Ops | -0.75 | -0.84 | -1.40 | 0.46 | -0.66 |
| EPS Basic Continuous Ops | -0.75 | -0.84 | -1.40 | 0.46 | -0.66 |
| EPS Diluted Total Ops | -0.75 | -0.84 | -1.40 | 0.46 | -0.66 |
| EPS Diluted Continuous Ops | -0.75 | -0.84 | -1.40 | 0.46 | -0.66 |
| EBITDA(a) | $-10,964 | $-11,411 | $-16,934 | $-11,783 | $-7,595 |